Novel Approaches in Pulmonary Fibrosis: Beyond the Fibroblast
Deadline Jan 30 2020 11:59 PM (EST)
Description

Event Date: March 24, 2020
Deadline to Submit Abstracts: January 30, 2020

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with few treatment options. Research on IPF and other interstitial lung diseases has historically focused on fibroblasts and the importance of TGF-beta-driven epithelial to mesenchymal transition. Recently, new data have highlighted key roles for additional cell types including alveolar epithelial cells and endothelial cells in the development or maintenance of lung fibrosis. Moreover, cellular senescence and immune pathways have also been found to contribute to IPF pathogenesis. This symposium will discuss the emerging biological mechanisms underlying the etiology of pulmonary fibrosis and explore novel ways to remove, repair or regenerate damaged lung.

To register for this event, please visit the main website at: www.nyas.org/LungFibrosis

Apply

Novel Approaches in Pulmonary Fibrosis: Beyond the Fibroblast


Event Date: March 24, 2020
Deadline to Submit Abstracts: January 30, 2020

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with few treatment options. Research on IPF and other interstitial lung diseases has historically focused on fibroblasts and the importance of TGF-beta-driven epithelial to mesenchymal transition. Recently, new data have highlighted key roles for additional cell types including alveolar epithelial cells and endothelial cells in the development or maintenance of lung fibrosis. Moreover, cellular senescence and immune pathways have also been found to contribute to IPF pathogenesis. This symposium will discuss the emerging biological mechanisms underlying the etiology of pulmonary fibrosis and explore novel ways to remove, repair or regenerate damaged lung.

To register for this event, please visit the main website at: www.nyas.org/LungFibrosis

Apply
Deadline
Jan 30 2020 11:59 PM (EST)